What we're reading, July 29, 2016: a trans-Atlantic partnership has been formed to fight superbugs; the FDA halted blood collections in 2 Florida counties over Zika fears; and investigation confirms Zika cases in Florida were from local mosquitoes.
A trans-Atlantic, public-private partnership has been formed to fight antibiotic-resistant bacteria, also known as superbugs. Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) grew out of a 2015 Obama administration initiative and will receive $250 million over the next 5 years from HHS, according to The Wall Street Journal. The venture will provide money to small companies and laboratories that are in the earliest stages of creating ways to combat superbugs.
The FDA has halted blood collection in 2 Florida counties amid a Zika virus probe. The Washington Post reported that while the counties are investigating possible local transmission of the virus, blood centers have been asked to stop collecting blood until they can implement the use of an approved or investigational pathogen-inactivation technology.
Friday morning Florida Governor Rick Scott confirmed that while no mosquitoes in the state have tested positive for Zika, the 4 infections being investigated likely came from local mosquitoes. AP reported that the infections were believed to have occurred in a small area north of downtown Miami. These cases represent the first cases of local transmission by mosquitos in the continental United States.
Unmet Needs Remain in Secondary AML Following Treatment With HMAs
January 18th 2025The study demonstrated a poor prognosis overall for patients with acute myeloid leukemia (AML) who were previously treated with hypomethylating agents (HMAs) for myeloid neoplasms such as myelodysplastic syndromes.
Read More
High HSP60 Expression Signals Poor Prognosis, Aggressive Tumors in Ovarian Cancer
January 16th 2025High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a prognostic biomarker.
Read More